DOTmed February 7, 2025
R. Kirk Huntsman

Obstructive sleep apnea (OSA) is a widespread but often overlooked condition, characterized by repeated interruptions in breathing during sleep. Despite affecting approximately 80 million adults in the U.S., an estimated 80% of cases go undiagnosed. Its impact extends far beyond disrupted rest, posing serious risks to cardiovascular health, cognitive function, and overall well-being.

For healthcare professionals, OSA represents a critical public health challenge. This widespread underdiagnosis not only compromises individual health but also contributes to an economic burden of $149.6 billion annually, driven by increased healthcare utilization, motor vehicles and workplace accidents, and lost productivity.

Traditional treatments like positive airway pressure (PAP) therapy and surgical interventions, while effective, often face patient adherence issues due to comfort and convenience concerns. Emerging...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Patient / Consumer, Provider
Healthcare, medtech industries brace for tariffs
Judge rules against FDA regulation of lab-developed tests
Medical device cybersecurity could be challenged by HHS staffing cuts
Psychiatric BCI Gears Up For Prime Time
Lantheus completes acquisition of radiopharma firm Evergreen Theragnostics for up to $1B

Share This Article